Biocept (Biocept) Other Operating Expense : $-0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Biocept Other Operating Expense?

Biocept's Other Operating Expense for the three months ended in Jun. 2023 was $-0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.00 Mil.

Biocept's quarterly Other Operating Expense increased from Dec. 2022 ($-0.00 Mil) to Mar. 2023 ($0.00 Mil) but then declined from Mar. 2023 ($0.00 Mil) to Jun. 2023 ($-0.00 Mil).

Biocept's annual Other Operating Expense declined from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($-0.00 Mil) but then increased from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($0.00 Mil).

Biocept Other Operating Expense Historical Data

The historical data trend for Biocept's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocept Other Operating Expense Chart

Biocept Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Operating Expense

Get a 7-Day Free Trial

Biocept Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

Biocept Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

Biocept Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Biocept's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocept (Biocept) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biocept Inc (OTCPK:BIOCQ) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

9955 Mesa Rim Road, San Diego, CA, USA, 92121

Website

https://www.biocept.com

Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide cerebrospinal fluid assay that detects cancer that has metastasized to the central nervous system. Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. It is also leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.

Executives

Robert Walsh	officer: VP, Controller	9955 MESA RIM ROAD, SAN DIEGO CA 92121
Quyen Thi Dao-haddock	director	C/O: PRESIDIO PROPERTY TRUST, INC., 1282 PACIFIC OAKS PLACE, ESCONDIDO CA 92029
Philippe Marchand	officer: Chief Operations Officer	C/O BIOCEPT, INC., 9955 MESA RIM ROAD, SAN DIEGO CA 92121
Darrell Taylor	officer: Sr. V.P., General Counsel	C/O BIOCEPT, INC., 9955 MESA RIM ROAD, SAN DIEGO CA 92121
David F Hale	director, officer: EXECUTIVE CHAIRMAN	1042-B NORTH EL CAMINO REAL, SUITE 430, ENCINITAS CA 92024
Antonino Morales	director	C/O BICOCEPT, INC., 9955 MESA RIM ROAD, SAN DIEGO CA 92121
Linda M Rubinstein	director	25861 INDUSTRIAL BLVD, HAYWARD CA 94545
Samuel D Riccitelli	director	2850 FRONTIER DR., WARSAW IN 46582
Michael C Dugan	officer: Chief Med Off & Med. Director	2211 MICHIGAN AVE, SANTA MONICA CA 90404-3900
Dunn Cory	officer: Sr. VP Corp. Development	C/O BIOCEPT, INC., 5810 NANCY RIDGE DR., # 150, SAN DIEGO CA 92121
Edwin Hendrick	officer: SVP, Chief Commercial Officer	2010 MAIN STREET, SUITE 600, IRVINE CA 92614
Michael J Terry	officer: Sr VP Comm. Operations
Marsha Alpert Chandler	director	7863 ENTRADA ANGELICA, SAN DIEGO CA 92127
Michael W. Nall	director, officer: CEO AND PRESIDENT	4 WOODHAVEN DRIVE, LAGUNA NIGUEL CA 92677
Timothy Kennedy	officer: CFO, Sr V.P. Operations & Sec.	5810 NANCY RIDGE DRIVE, SUITE 150, SAN DIEGO CA 92121